Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis

Breast Cancer Research and Treatment

Volumn 149, Issue 1, 2015, Pages

  Dowsett, Mitch ^a,b,c   Folkerd, Elizabeth ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Breakthrough Breast Cancer Research Centre   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Estrogen; Menstrual cycle; Obesity; Postmenopausal; Premenopausal; Progesterone

Indexed keywords

ANDROGEN; AROMATASE; ESTROGEN; PROGESTERONE;

BIOSYNTHESIS; BREAST TUMOR; COMPLICATION; FEMALE; HUMAN; METABOLISM; OBESITY; PATHOLOGY; PREMENOPAUSE;

ANDROGENS; AROMATASE; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; OBESITY; PREMENOPAUSE; PROGESTERONE;

EID: 84922103927     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3211-4     Document Type: Review

References (13)

1. Bhaskaran K, Douglas I, Forbes H et al (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765
2. Schmitz KH, Neuhouser ML, Agurs-Collins T et al (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105:1344–1354
3. Key TJ, Appleby PN, Reeves GK et al (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226
4. Polotsky AJ, Hailpern SM, Skurnick JH et al (2010) Association of adolescent obesity and lifetime nulliparity-the study of women’s health across the nation (SWAN). Fertil Steril 93:2004–2011
5. Gaudet MM, Gapstur SM, Sun J et al (2014) Oophorectomy and hysterectomy and cancer incidence in the cancer prevention study-II nutrition cohort. Obstet Gynecol 123:1247–1255
6. Jain A, Polotsky AJ, Rochester D et al (2007) Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab 92:2468–2473
7. Rochester D, Jain A, Polotsky AJ et al (2009) Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril 92:1410–1415
8. Briskin C (2013) Progesterone signaling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 13:385–396
9. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288:321–333
10. Beral V, Reeves G, Bull D et al (2011) Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 103:296–305
11. Topal NB, Ayhan S, Topal U et al (2006) Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins. J Obstet Gynecol Res 32:305–308
12. Reeves GK, Pirie K, Beral V et al (2007) Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. doi:10.1136/bmj.39367.495995.AE
13. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591